References
- Neijt J. P. Treatment of advanced ovarian cancer: 10 years of experience. Review. Ann Oncol 1992; 3: 17–27
- Peterson C., Masquelier M., Rudling M., Söderberg K., Vitols S. Lipoprotein, malignancy, and anticancer agents. Lipoproteins as carriers of pharmacological agents, J. M. Shaw. Marcel Dekker Inc, New York 1991; 175–200
- Goldstein J. L., Brown M. S. Atherosclerosis: the low-density lipoprotein receptor hypothesis. Metabolism 1977; 26: 1257–75
- Shepherd J., Bicker S., Lorimer A. R., Packard C. J. Receptor-mediated low density lipoprotein catabolism in man. J Lipid Res 1979; 20: 999–1006
- Budd D., Ginsberg H. Hypocholesterolemia and acute myelogenous leukemia. Association between disease activity and plasma low-density lipoprotein cholesterol concentrations. Cancer 1986; 58: 1361–5
- Vitols S., Gahrton G., Björkholm M., Peterson C. Hypocholesterolemia in malignancy due to elevated elevated LDL receptor activity in tumour cells; evidence from studies in leukemic patients. Lancet 1985; 2: 1150–4
- Feinleib M. Review of the epidemiological evidence for a possible relationship between hypocholesterolemia and cancer. Cancer Res 1983; 43: 2503–7
- Alexopoulos C. G., Blatsios B., Averginos A. Serum lipids and lipoprotein disorders and cancer patients. Cancer 1987; 60: 3065–70
- Pettersson F. Annual report on the results of treatment in gynecological cancer. 21 vol. Int J Gynecol Obstet 1991; 36((Suppl))27–130
- Levinson S., Wagner S. Immunonephelometric/turbidimetric apolipoprotein B assays for the clinical laboratory. Clin Chim Acta 1993; 223: 31–42
- Vitols S., Peterson C., Larsson O., Holm P., Åberg B. Elevated uptake of low density lipoproteins by human lung cancer tissue in vivo. Cancer Res 1992; 52: 6244–7